• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于免疫毒素疗效筛选的各种体外试验的比较。

Comparison of various in vitro assays for efficacy screening of immunotoxins.

作者信息

Post J, Vooys W C, de Gast G C, Bast B J

机构信息

Department of Haematology, University Hospital, Utrecht, The Netherlands.

出版信息

Leuk Res. 1995 Apr;19(4):241-7. doi: 10.1016/0145-2126(94)00142-w.

DOI:10.1016/0145-2126(94)00142-w
PMID:7752671
Abstract

Before using immunotoxins in vivo, their efficacy is evaluated in in vitro assays. In this study we compare six different assays for the evaluation of immunotoxins: protein and DNA synthesis inhibition assay, chromium release assay, cell line colony assay, limiting dilution assay and clonogenic assay. All assays except the chromium release assay show specificity of the immunotoxins in appropriate concentrations. The protein and DNA synthesis inhibition assays are easy to perform and, therefore, suitable for initial screening, while the clonogenic assay seems to be the best one for immunotoxin efficacy determination.

摘要

在体内使用免疫毒素之前,需在体外试验中评估其疗效。在本研究中,我们比较了六种用于评估免疫毒素的不同试验:蛋白质和DNA合成抑制试验、铬释放试验、细胞系集落试验、有限稀释试验和克隆形成试验。除铬释放试验外,所有试验均显示免疫毒素在适当浓度下具有特异性。蛋白质和DNA合成抑制试验易于操作,因此适用于初步筛选,而克隆形成试验似乎是确定免疫毒素疗效的最佳试验。

相似文献

1
Comparison of various in vitro assays for efficacy screening of immunotoxins.用于免疫毒素疗效筛选的各种体外试验的比较。
Leuk Res. 1995 Apr;19(4):241-7. doi: 10.1016/0145-2126(94)00142-w.
2
Methods for quantifying immunotoxin efficacy.免疫毒素疗效的定量方法。
Cancer Treat Res. 1988;37:393-404. doi: 10.1007/978-1-4613-1083-9_21.
3
Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.抗转铁蛋白受体免疫毒素对正常及白血病人类造血祖细胞的细胞毒活性。
Cancer Res. 1991 Jan 15;51(2):536-41.
4
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
Cancer. 1991 Sep 15;68(6):1272-8. doi: 10.1002/1097-0142(19910915)68:6<1272::aid-cncr2820680616>3.0.co;2-l.
5
Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.转铁蛋白受体靶向免疫毒素在脑肿瘤细胞系和小儿脑肿瘤中的疗效。
Cancer Res. 1993 Mar 15;53(6):1348-53.
6
Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.抗p185HER-2蓖麻毒素A链免疫毒素与放射性核素缀合物之间的协同相互作用,用于抑制过表达HER-2的卵巢癌细胞和乳腺癌细胞的生长。
Clin Cancer Res. 2000 Aug;6(8):3334-41.
7
In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Cancer Res. 1994 Sep 1;54(17):4684-90.
8
New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.用于合成含受阻二硫键且在体内稳定性提高的免疫毒素的新型偶联剂。
Cancer Res. 1987 Nov 15;47(22):5924-31.
9
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells.联合使用免疫毒素抑制人乳腺癌细胞的克隆生长。
Cancer Res. 1990 Jun 1;50(11):3231-8.
10
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.偶联型利妥昔单抗/皂草素-S6可完全抑制表达CD20细胞的克隆形成生长,并与氟达拉滨产生协同毒性作用。
Leukemia. 2004 Jul;18(7):1215-22. doi: 10.1038/sj.leu.2403378.

引用本文的文献

1
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.B7-1(CD80)作为霍奇金病免疫毒素治疗的靶点。
Br J Cancer. 1997;76(9):1163-9. doi: 10.1038/bjc.1997.528.